Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT

被引：0

作者：

Mohty, Mohamad ^{[1
]}

Labopin, Myriam ^{[2
]}

Finke, Jurgen ^{[3
]}

Schmid, Christoph ^{[4
]}

Kolb, H. J. ^{[5
]}

Bacigalupo, Andrea ^{[6
]}

Blaise, Didier ^{[7
]}

Cornillon, Jerome ^{[8
]}

Milpied, Noel

Cabrera-Marin, J. R. ^{[9
]}

Ciceri, Fabio ^{[10
]}

Rocha, Vanderson ^{[11
]}

Nagler, Arnon ^{[12
]}

机构：

[1] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France

[2] Univ UPMC, Dept Hematol Oncol, EBMT ALWP Registry, Fac Med St Antoine, Paris, France

[3] Univ Freiburg Klinikum, Dept Med 1, Freiburg, Germany

[4] Med Klin 2, Augsburg, Germany

[5] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany

[6] San Martino Hosp, Genoa, Italy

[7] Inst J Paoli I Calmettes, F-13009 Marseille, France

[8] Inst Cancerol Loire, F-42270 St Priest En Jarez, France

[9] Clin Puerta de Hierro, Madrid, Spain

[10] Ist Sci HS Raffaele, Milan, Italy

[11] Hop St Louis, Paris, France

[12] Tel Aviv Univ, Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1414 / 1414

页数：1

共 50 条

[31] Fludarabine, Low Dose Busulfan and Antithymocyte Globulin for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) [J].

Malard, F. ;

Brissot, Eolia ;

Chevallier, Patrice ;

Guillaume, Thierry ;

Delaunay, Jacques ;

Ayari, Sameh ;

Dubruille, Viviane ;

Le Gouill, Steven ;

Mahe, Beatrice ;

Gastinne, Thomas ;

Blin, Nicolas ;

Saulquin, Beatrice ;

Harousseau, Jean-Luc ;

Moreau, Philippe ;

Milpied, Noel-Jean ;

Mohty, Mohamad .

BLOOD, 2009, 114 (22) :1296-1297

[32] IMPACT OF CYTOGENETICS RISK ON OUTCOME AFTER REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FROM AN HLA IDENTICAL SIBLING FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CRI) [J].

Mobty, M. ;

Labopin, M. ;

Milpied, N. ;

Cornelissen, J. J. ;

Blaise, D. ;

Petersen, E. ;

Theorin, N. ;

Goker, H. ;

Socie, G. ;

Rocha, V .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) :21-21

[33] Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen A Report from the Acute Leukemia Working Party of the EBMT [J].

Savani, Bipin N. ;

Labopin, Myriam ;

Polge, Emmanuelle ;

Kroeger, Nicolaus ;

Finke, Jurgen ;

Ehninger, Gerhard ;

Niederwieser, Dietger ;

Kyrcz-Krzemien, Slawomira ;

Schwerdtfeger, Rainer ;

Bunjes, Donald W. ;

Glass, Bertrum ;

Socie, Gerard ;

Ljungman, Per T. ;

Mohty, Mohamad ;

Nagler, Arnon .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) :S68-S69

[34] Impact of plasmacytoid dendritic cell (PDC) recovery on outcome after reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (Allo-SCT). [J].

Mohty, M ;

Blaise, D ;

Faucher, C ;

Bardou, VJ ;

Gastaut, JA ;

Viens, P ;

Olive, D ;

Gaugler, B .

BLOOD, 2004, 104 (11) :35B-35B

[35] Impact of plasmacytoid dendritic cell (PDC) recovery on outcome after reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) [J].

Mohty, M ;

Blaise, D ;

Faucher, C ;

Gastaut, JA ;

Viens, P ;

Olive, D ;

Gaugler, B .

EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) :48-48

[36] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with refractory or relapsed non-Hodgkin's lymphoma (NHL). [J].

de Lavallade, Hugues ;

Bouabdallah, Reda ;

Faucher, Catherine ;

Furst, Sabine ;

El-Cheikh, Jean ;

Vey, Norbert ;

Stoppa, Anne-Marie ;

Sainty, Danielle ;

Amoulet, Christine ;

Xerri, Luc ;

Cassier, Philippe ;

Gastaut, Jean-Albert ;

Blaise, Didier ;

Mohty, Mohamad .

BLOOD, 2006, 108 (11) :432B-432B

[37] Allogeneic stem cell transplantation (allo-SCT) in adult acute lymphoblastic leukemia (ALL) [J].

Wu, S. J. ;

Yao, M. ;

Tang, J. L. ;

Chen, Y. C. ;

Cheng, A. L. ;

Tien, H. F. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

[38] Allogeneic stem cell transplantation (allo-SCT) in patients with advanced-phase acute leukemia [J].

Michalakeas, I ;

Baltathakis, I ;

Karakasis, D ;

Delistrati, V ;

Poulopoulou, Z ;

Bika, E ;

Skandalis, A ;

Harhalakis, N ;

Nikiforakis, E .

BONE MARROW TRANSPLANTATION, 2002, 29 :S81-S81

[39] Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed/Refractory Hodgkin Lymphoma in the Brentuximab Vedotin Era [J].

Anderlini, P. ;

Saliba, R. ;

Ledesma, C. ;

Plair, T. ;

Alousi, A. ;

Hosing, C. ;

Khouri, I. ;

Nieto, Y. ;

Popat, U. ;

Shpall, E. ;

Fanale, M. ;

Oki, Y. ;

Neelapu, S. ;

Younes, A. ;

Champlin, R. .

BONE MARROW TRANSPLANTATION, 2016, 51 :S70-S71

[40] Outcomes of second allogeneic hematopoietic stem cell Transplantation (Allo-SCT) in patients with acute lymphoblastic leukemia (ALL) [J].

Al Malki, Monzr M. ;

Aldoss, Ibrahim ;

Forman, Stephen J. ;

Stiller, Tracey ;

Pullarkat, Vinod A. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 :S175-S175

← 1 2 3 4 5 →